Table 2 Frequency of adverse events among the three groups.
Adverse events | Not receiving fluconazole | Receiving fluconazole | Pvalue | |
|---|---|---|---|---|
(n = 225) | 400 mg/week (n = 392) | 200 mg/day (n = 69) | ||
Clinical hepatitis | 2/225 (0.9%) | 4/392 (1.0%) | 0/69 (0%) | 0.705 |
Elevated AST > 3 times from baseline | 3/104 (2.9%) | 5/188 (2.7%) | 3/36 (8.3%) | 0.192 |
Elevated ALT > 3 times from baseline | 6/71 (8.5%) | 7/95 (7.4%) | 2/22 (9.1%) | 0.938 |
Skin Rash | 23/225 (10.2%) | 27/392 (6.9%) | 0/69 (0%) | 0.016 |